Alok Sonig in

Alok Sonig

Login to view DISC.
Chief Executive Officer at Rosemont Pharmaceuticals
📍 Princeton, New Jersey, United States

Alok Sonig is a global pharmaceutical leader with nearly three decades of experience, currently serving as the CEO of Rosemont Pharmaceuticals. His career includes executive roles at Baxter, Lupin, and Dr. Reddys, where he built a reputation for driving growth and leading high-impact teams. He holds an MBA from American University.

He has a strong focus on patient outcomes, believing the industry is shifting from a molecule-centric to a patient-centric approach. He advocates for improving medication access and adherence for patients with complex needs, such as those with swallowing difficulties, to ensure dignity in care.

He is an advisory board member at the Kogod School of Business, American University.

Read the full overview →
Experience
30 Years
Current Role
Chief Executive Officer
Job Level
Leadership
Location
Princeton, New Jersey, United States
Personality Overview

How Alok shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Alok cares about

Patient-Centric Outcomes
Champions a shift from molecule-focused development to improving patient outcomes through better formulations, support services, and access, as discussed in a recent podcast.
Specialty Pharmaceuticals
Focuses on innovating within the specialty pharma landscape to meet the needs of specific patient populations, particularly those with swallowing difficulties (dysphagia).
+5 more topics Login to view topics
Career

Work history

1-2026
Chief Executive Officer
Rosemont Pharmaceuticals
3-2023 - 12-2025
Executive Vice President & Group President, Pharmaceuticals
Baxter International Inc.
6-2022 - 2-2023
President, Pharmaceuticals Business Unit
Baxter International Inc.
9-2018 - 6-2022
CEO, US Generics and Global Head, Generics R&D and Biosimilars
Lupin
4-2018 - 8-2018
CEO, Developed Markets (North America, Europe, Japan)
Dr. Reddy's Laboratories
In the press

Media appearances

Rosemont Announces New CEO – Alok Sonig. Featured in Rosemont Pharmaceuticals (company press release)
See now
A Conversation with Alok Sonig, CEO of Rosemont Pharma. Featured in Alantra – Crossroads Podcast
+3 more appearances Login to view media
Education
1992 - 1994
Master of Business Administration (MBA)
American University - Kogod School of Business
1988 - 1992
Bachelor of Engineering (B.E.)
Punjab Engineering College
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Matt Ivey
Matt Ivey
Owner
Ivey Homes
 Douglas Bingham
Douglas Bingham
Chief Financial Officer
FieldStone Homes
 Kellie Little
Kellie Little
Vice President of Sales & Marketing
Century Communities, Inc. (NYSE:CCS)
 Travis Schloderer
Travis Schloderer
Community Sales Manager
FieldStone Homes
Unlock the full playbookSee exactly how to sell to Alok. Free, 10 seconds.